Welcome to our dedicated page for UNITEDHEALTH GROUP SEC filings (Ticker: UNH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on UNITEDHEALTH GROUP's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into UNITEDHEALTH GROUP's regulatory disclosures and financial reporting.
UNITEDHEALTH GROUP INC executive Patrick Hugh Conway, Chief Executive Officer of Optum, reported equity compensation and a related tax share disposition. He was granted 35,517 non-qualified stock options with an exercise right to buy shares, and 8,855 shares of common stock as a stock award. Both awards vest in four equal installments of 25% on February 23 of each year from 2027 through 2030. To satisfy tax obligations on equity, 178.988 shares of common stock were disposed of at $282.34 per share, leaving him with 18,479.97 common shares held directly after these transactions.
DeVeydt Wayne S reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group’s Chief Financial Officer Wayne S. DeVeydt reported equity awards that increase his direct ownership in the company. He was granted non-qualified stock options for 35,517 shares on February 23, 2026, and a separate award of 8,855 shares of common stock at $282.34 per share.
The common stock award and related restricted stock units vest in 25% increments each February 23 from 2027 through 2030. The stock options follow the same vesting schedule, also vesting 25% annually on those dates. These awards are classified as grants or awards rather than open-market purchases.
UnitedHealth Group updated the terms of a stock option previously granted to Stephen Hemsley. The grant, originally issued on May 14, 2025 with three-year cliff vesting, now carries a two-year share holding requirement after vesting.
Hemsley must hold any net shares obtained from exercising this option until May 14, 2030, reinforcing longer-term alignment with shareholders. The only exceptions are in cases of death or disability, and all other terms of the stock option remain unchanged.
UnitedHealth Group executive Erin McSweeney reported two insider transactions involving company common stock. On February 20, 2026, she disposed of 136.641 shares and 155.182 shares at $290.00 per share, both coded as F transactions, meaning shares were withheld to cover tax liabilities rather than sold on the open market.
UnitedHealth Group executive Christopher R. Zaetta reported two tax-related share dispositions. On February 20, 2026, he surrendered 130.851 and 312.436 shares of UnitedHealth common stock at a stated value of $290 per share to cover taxes by delivering shares rather than paying cash.
After these withholding transactions, his directly held balances reported in the filing were 9,984.430 shares following the first disposition and 9,671.994 shares following the second, reflecting routine administrative adjustments tied to equity compensation.
UNITEDHEALTH GROUP INC executive Patrick Hugh Conway, Chief Executive Officer of Optum, reported two Form 4 transactions involving common stock. On February 20, 2026, he disposed of 249.6400 and 254.9080 shares at $290.00 per share as tax-withholding dispositions, meaning shares were withheld to cover tax obligations rather than sold on the open market. After these transactions, his directly owned common stock holdings were reported at 9,803.9580 shares.
UNITEDHEALTH GROUP INC executive Timothy John Noel reported tax-related share dispositions under a Form 4. On February 20, 2026, he used 152.599 and 311.958 shares of common stock, each at $290.00 per share, to cover tax obligations. After these non-market transactions, he directly owned 8,740.495 common shares.
UnitedHealth Group Chief Accounting Officer Thomas E. Roos reported two tax-withholding share dispositions tied to equity compensation. On February 20, 2026, he surrendered a total of 326.067 shares of common stock in transactions coded “F” at $290.0000 per share to cover tax liabilities, leaving him with 28,999.418 shares of UnitedHealth common stock held directly.
ROOS THOMAS E reported disposition transactions in a Form 4 filing for UNH. The filing lists transactions totaling 322 shares at a weighted average price of $293.19 per share. Following the reported transactions, holdings were 29,325 shares.
Zaetta Christopher R reported disposition transactions in a Form 4 filing for UNH. The filing lists transactions totaling 213 shares at a weighted average price of $293.19 per share. Following the reported transactions, holdings were 10,115 shares.